Mizuho Maintains Buy on Surgery Partners, Raises Price Target to $50
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Ann Hynes maintains a 'Buy' rating on Surgery Partners (NASDAQ:SGRY) and raises the price target from $48 to $50.
July 11, 2023 | 11:55 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mizuho analyst maintains a 'Buy' rating on Surgery Partners and raises the price target from $48 to $50.
The news is directly related to Surgery Partners. The 'Buy' rating maintained by Mizuho and the increase in price target from $48 to $50 indicates a positive outlook for the company. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100